Diabetes, Vol 49, Issue 9 1579-1584, Copyright © 2000 by American Diabetes Association

ARTICLES

Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage

TM Osicka, CA Houlihan, JG Chan, G Jerums and WD Comper
Department of Medicine, Austin & Repatriation Medical Center, University of Melbourne, Heidelberg, Victoria, Australia.

Previous studies by our group have shown that albumin is metabolized in rodents during renal passage and excreted in the urine as a mixture of intact protein and albumin-derived fragments. The aim of this study was to examine whether albumin is metabolized during renal passage in nondiabetic volunteers and in type 1 diabetic patients with varying levels of albuminuria. Nine nondiabetic normoalbuminuric volunteers and 11 type 1 diabetic patients with albumin excretion rates varying from normoalbuminuria to macroalbuminuria were studied. Each subject received an intravenous injection of tritium-labeled albumin ([3H]-albumin). Urine was collected at 4 h and 24 h after injection and analyzed by size exclusion chromatography. The amount of intact and fragmented albumin was quantified, and each fraction was analyzed by radioimmunoassay (RIA) for albumin. [3H]-albumin in nondiabetic volunteers was metabolized during renal passage to small peptide fragments not detectable by conventional RIA (only 0.05-3.8% of the total urinary radioactivity was associated with intact albumin). The process responsible for albumin fragmentation was similar in diabetic patients with normoalbuminuria (intact albumin represented 0.01-4.0% of total urinary radioactivity). However, there was a reduction in the fragmentation ratio (fragmented:intact) in diabetic patients with micro- or macroalbuminuria (intact albumin represented 2.7-55.5%, P = 0.048). This change in the fragmentation ratio was directly related to the degree of albuminuria. These results have important implications for understanding the mechanisms underlying albuminuria in nondiabetic volunteers and type 1 diabetic patients. In nondiabetic volunteers, the renal processing of albumin involves a relatively rapid and comprehensive degradation of albumin to small fragments (range 1-15 kDa). The degradation process is inhibited in diabetic nephropathy in proportion to the level of albuminuria detected by RIA.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. S. Goligorsky, F. Addabbo, and E. O'Riordan Diagnostic Potential of Urine Proteome: A Broken Mirror of Renal Diseases J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2233 - 2239. [Abstract] [Full Text] [PDF]

				L. M. Russo, E. del Re, D. Brown, and H. Y. Lin Evidence for a Role of Transforming Growth Factor (TGF)-{beta}1 in the Induction of Postglomerular Albuminuria in Diabetic Nephropathy: Amelioration by Soluble TGF-{beta} Type II Receptor Diabetes, February 1, 2007; 56(2): 380 - 388. [Abstract] [Full Text] [PDF]

				N. Babic, T.S. Larson, S.K. Grebe, S.T. Turner, R. Kumar, and R.J. Singh Application of liquid chromatography-mass spectrometry technology for early detection of microalbuminuria in patients with kidney disease. Clin. Chem., November 1, 2006; 52(11): 2155 - 2157. [Full Text] [PDF]

				B. L. West, M. M. Picken, and D. J. Leehey Albuminuria in acute tubular necrosis Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2953 - 2956. [Full Text] [PDF]

				R. A. Ward Protein-Leaking Membranes for Hemodialysis: A New Class of Membranes in Search of an Application? J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2421 - 2430. [Abstract] [Full Text] [PDF]

				T. Peters Jr New Form of Urinary Albumin in Early Diabetes Clin. Chem., December 1, 2004; 50(12): 2238 - 2239. [Full Text] [PDF]

				T. M. Osicka and W. D. Comper Characterization of Immunochemically Nonreactive Urinary Albumin Clin. Chem., December 1, 2004; 50(12): 2286 - 2291. [Abstract] [Full Text] [PDF]

				W. D. Comper, G. Jerums, and T. M. Osicka Deficiency in the Detection of Microalbuminuria by Urinary Dipstick in Diabetic Patients Diabetes Care, November 1, 2003; 26(11): 3195 - 3196. [Full Text] [PDF]

				G. Wolf and E. Ritz Diabetic Nephropathy in Type 2 Diabetes Prevention and Patient Management J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1396 - 1405. [Full Text] [PDF]

				G. Gambaro, I. Kinalska, A. Oksa, P. Pont'uch, M. Hertlova, J. Olsovsky, J. Manitius, D. Fedele, S. Czekalski, J. Perusicova, et al. Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients: The Di.N.A.S. Randomized Trial J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1615 - 1625. [Abstract] [Full Text] [PDF]

				L. M. Russo, T. M. Osicka, F. Bonnet, G. Jerums, and W. D. Comper Albuminuria in Hypertension Is Linked to Altered Lysosomal Activity and TGF-{beta}1 Expression Hypertension, February 1, 2002; 39(2): 281 - 286. [Abstract] [Full Text] [PDF]

				W. D. Comper ;, B. Haraldsson, M. Ohlson, and J. Sorensson Charge Selectivity is a Concept That Has Yet to be Demonstrated Am J Physiol Renal Physiol, November 1, 2001; 281(5): F992 - F993. [Full Text] [PDF]

				K. A. Greive, N. D.H. Balazs, and W. D. Comper Protein Fragments in Urine Have Been Considerably Underestimated by Various Protein Assays Clin. Chem., September 1, 2001; 47(9): 1717 - 1719. [Full Text] [PDF]

				K. A. Greive, D. J. Nikolic-Paterson, M. A. M. Guimaraes, J. Nikolovski, L. M. Pratt, W. Mu, R. C. Atkins, and W. D. Comper Glomerular Permselectivity Factors Are Not Responsible for the Increase in Fractional Clearance of Albumin in Rat Glomerulonephritis Am. J. Pathol., September 1, 2001; 159(3): 1159 - 1170. [Abstract] [Full Text] [PDF]